Hazelden Betty Ford Foundation- Updates in Methamphetamine Use Disorder Virtual Training
Free Webinar: Methamphetamine is a rapidly emerging threat and a critical public health and safety concern across the Commonwealth of Kentucky. Methamphetamine use has profound physical and psychological impacts on individuals and families and has been felt in communities in all areas of the state. According to the “2019 Overdose Fatality Report,” recently released by the Kentucky Office of Drug Control Policy, there has been a nearly 50% increase in methamphetamine-related adverse events and a 25% increase in related overdoses in Kentucky over the past two years. Due to its wide range of psychological and physical effects, methamphetamine use is a concern for healthcare professionals across all Kentucky healthcare settings. Any health interaction is an opportunity to discuss methamphetamine use; and primary care professionals can play an important role in effectively identifying patients with use disorders, provide counseling on available treatment and facilitate referrals, when appropriate. _____________________________________________
TRAINER BIO Kerry Hettinger, PharmD, RPh Dr. Hettinger a registered pharmacist in Kentucky and Indiana and has served as a PharmD Trainer and Technical consultant for the Hazelden Betty Ford Foundation Professional Education Continuum Solutions Division since 2017. She currently serves on the Board of Directors for the Kentucky Harm Reduction Coalition and is an active member in several professional pharmacy organization promoting the role of the pharmacist in the multidisciplinary addiction care team. In her role as PharmD TTA Consultant, Dr. Hettinger has been passionately involved in providing pharmacotherapy education on addiction and addictive substances to healthcare professionals across the United the States. She has authored many presentations focused on the neurobiology and treatment of substance use disorders, psychopharmacology, medications for the treatment of opioid use disorder, and opioid stewardship initiatives. Dr. Hettinger has appeared as a featured speaker at several State Opioid Conferences and continues to provide direct training and clinical consultative services to healthcare professionals across healthcare settings. Prior to joining the Hazelden Betty Ford Foundation, Dr. Hettinger held positions in Kentucky independent and corporate retail pharmacies where she was involved in launching state’s first pharmacy-delivered addiction services.
At the end of this 2 Hr. training participants will be able to: 1. Describe the pharmacological mechanism of action for methamphetamine’s stimulant effects 2. Identify signs and symptoms of methamphetamine intoxication and withdrawal 3. Discuss the acute and chronic effects of methamphetamine use 4. Review the current evidence for pharmacological treatment interventions for methamphetamine use disorders